---
title: "Provision of Breyanzi CAR POS T-Cells"
ocid: "ocds-h6vhtk-06e577"
canonical_url: "https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06e577"
markdown_url: "https://d3tenders.com/contract/ocds-h6vhtk-06e577.md"
json_url: "https://d3tenders.com/contract/ocds-h6vhtk-06e577.json"
source: "Find A Tender Service"
current_stage: "Award"
buyer: "The Clatterbridge Cancer Centre NHS Foundation Trust"
published: "2026-08-17"
---

# Provision of Breyanzi CAR POS T-Cells

Buyer: The Clatterbridge Cancer Centre NHS Foundation Trust  
Current stage: Award  
OCID: ocds-h6vhtk-06e577

[View canonical contract page](https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06e577)  
[Download OCDS JSON](https://d3tenders.com/contract/ocds-h6vhtk-06e577.json)

## Summary

The Clatterbridge Cancer Centre NHS Foundation Trust bought Breyanzi CAR T-cells, a pharmaceutical product supplied directly to the NHS. The purchase was commissioned through NHS England and relates to the Trust, whose address is on Clatterbridge Road in Bebington, Wirral. Breyanzi is a specialised cell therapy product, so this requirement is relevant to pharmaceutical manufacturers, authorised distributors and organisations able to supply advanced cancer treatments directly into NHS arrangements. The procurement covers one completed lot and the product classification is pharmaceutical products. The requirement is for supply rather than construction, consultancy or general healthcare services, making it most relevant to businesses with an established capability in specialist oncology medicines and NHS supply arrangements.

The procurement is complete and was awarded by direct award to BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED. The buyer’s stated rationale was that NHS England commissioned the service with a single supplier only, citing technical reasons. The award and contract date was 17 August 2026. The principal award and contract value is £140,250 gross, with a contract period from 17 August 2026 to 18 August 2026. A second active award is recorded for the same lot and supplier, with a contract value of £0 and the same period. The process used one lot, was above threshold for the principal award and contract, and was not evaluated through a competitive tender because the stated route was a direct award.

This completed procurement demonstrates demand from a specialist NHS cancer provider for direct supply of an advanced pharmaceutical product commissioned through NHS England. A supplier seeking to compete for a future requirement of this kind would need access to Breyanzi or an equivalent authorised product, the legal ability to place and supply specialist medicines in the UK, and robust arrangements for direct delivery to the NHS. Credibility would also depend on demonstrating that the product is clinically and technically suitable, that supply can be maintained at the required scale, and that the business can work within NHS England commissioning and purchasing arrangements. The direct-award rationale indicates that single-supplier technical considerations were central to this purchase.

## Notice

Purchase of Breyanzi CAR POS T-Cells, products to be supplied direct; commissioned via NHS England.

### Procurement Information

Commissioned by NHS England with single supplier only for this service

## Key Details

| Field | Value |
| --- | --- |
| Publication source | Find A Tender Service |
| Latest notice | https://www.find-tender.service.gov.uk/Notice/078044-2026 |
| Notice type | UK7 - Contract Details Notice |
| Procurement type | Standard |
| Procurement category | Goods |
| Procurement method | Direct |
| Procurement method details | Direct award |
| Tender suitability | Not specified |
| Awardee scale | SME |
| All stages | Award |

## Dates

| Field | Value |
| --- | --- |
| Publication date | 17 Aug 2026 |
| Submission deadline | Not specified |
| Future notice date | Not specified |
| Award date | 17 Aug 2026 |
| Contract period | 17 Aug 2026 - 18 Aug 2026 |
| Recurrence | Not specified |

## Values

| Field | Value |
| --- | --- |
| Tender value | Not specified |
| Lots value | Not specified |
| Awards value | £140,250 |
| Contracts value | £140,250 |

## Status

| Field | Value |
| --- | --- |
| Tender status | Complete |
| Lots status | Complete |
| Awards status | Active |
| Contracts status | Active |

## Buyer

| Field | Value |
| --- | --- |
| Main buyer | The Clatterbridge Cancer Centre NHS Foundation Trust |
| Locality | BEBINGTON, WIRRAL |
| Postcode area | Chester |
| Postcode | CH63 4JY |
| Country | England |
| ITL 1 | TLD North West (England) |
| ITL 2 | TLD7 Merseyside |
| ITL 3 | TLD74 Wirral |
| Local authority | Wirral |
| Electoral ward | Clatterbridge |
| Westminster constituency | Wirral West |
| Delivery location | Not specified |

## Supplier

| Field | Value |
| --- | --- |
| Number of suppliers | 1 |
| Supplier names | BRISTOL-MYERS SQUIBB PHARMACEUTICALS LIMITED |

## CPV Codes

### Divisions

- 33 - Medical equipments, pharmaceuticals and personal care products

### Codes

- 33600000 - Pharmaceutical products

## Release History

- 17 Aug 2026 at 11:43 - Award - UK7 - Contract Details Notice - https://www.find-tender.service.gov.uk/Notice/078044-2026
- 17 Aug 2026 at 11:32 - Award - UK5 - Transparency Notice - https://www.find-tender.service.gov.uk/Notice/078039-2026

## Documents

- https://www.find-tender.service.gov.uk/Notice/078044-2026
  17th August 2026 - Contract details notice on Find a Tender
- https://www.find-tender.service.gov.uk/Notice/078039-2026
  17th August 2026 - Transparency notice on Find a Tender

## Notice URLs

- https://www.bms.com/
- https://www.clatterbridgecc.nhs.uk/
- https://www.legislation.gov.uk/ukpga/2023/54/contents

## Provenance

This Markdown file is an alternate public rendering of the D3 Tenders contract record. The canonical page is https://d3tenders.com/contract/?ocid=ocds-h6vhtk-06e577. The underlying structured data is available as OCDS JSON at https://d3tenders.com/contract/ocds-h6vhtk-06e577.json.